© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Iopamidol stands out as a non-ionic, water-soluble contrast agent widely used in medical imaging. This compound, discovered in the late 20th century, offers radiologists an important tool for performing X-ray-based diagnostic procedures like CT scans and angiography. Physicians rely on Iopamidol for its high level of detail, which helps detect structural abnormalities or monitor existing medical conditions. Iopamidol’s broad clinical application grew from its chemical stability, safety profile, and reliable performance in producing clear, accurate images.
The molecular formula of Iopamidol is C17H22I3N3O8, and its molar mass reaches approximately 777.09 g/mol. The molecular structure contains three iodine atoms, which play a crucial role in absorbing X-rays and generating contrast on medical images. Iopamidol’s backbone, built on amide and glucose-derived units, enhances its solubility in water. The density varies based on concentration in solution, but as a solid, it registers at about 2.09 g/cm³. In its purest form, Iopamidol appears as a white or off-white crystalline powder, free from strong odor and generally stable under recommended storage. The substance is non-volatile, and its high level of purity helps prevent impurities from interfering with image quality.
Iopamidol reaches the market and laboratory environments in several presentations. As a raw material, it usually comes as a fine powder or sometimes as solid flakes or pearls. In clinical practice, it typically appears as a clear, colorless to pale yellow sterile solution ready for injection, prepared under strict pharmaceutical standards. The solution's concentration often varies from 200 mg Iodine/mL to 370 mg Iodine/mL. The pH of these solutions lies near neutrality, typically between 6.5 and 7.7, helping to reduce irritation upon administration. Specifications for pharmaceutical use include tests for sterility, absence of particulate matter, and low osmolality, which reduces adverse effects. Iopamidol in solid form remains highly stable and non-hygroscopic, allowing for easy transport and long-term storage without degradation.
Worldwide trade and distribution of Iopamidol recognize its unique Harmonized System (HS) Code: 29242990. Safety forms the backbone of Iopamidol’s clinical recommendations. Acute toxicity is low, but users might encounter hypersensitivity reactions in rare cases. Healthcare providers must screen patients for iodine allergies or previous adverse reactions to contrast agents. The compound excretes mainly through the kidneys, which places special considerations when used in patients with renal impairment. Material safety data sheets (MSDS) categorize Iopamidol as a non-flammable, non-explosive compound, but large quantities should still be stored securely and away from incompatible chemicals. Proper labeling, handling procedures, and accessible safety gear help prevent accidental exposure during preparation or administration. Regulations classify unused solutions and empty containers as pharmaceutical waste and demand lawful, environmentally sound disposal methods.
Radiology technicians, pharmacists, and clinicians find Iopamidol’s reliability crucial for high-stakes diagnostic exams. Its rapid distribution within the vascular system delivers sharp, immediate enhancement for X-ray-based imaging. Because the injection process happens quickly, supporting staff teams must stay trained and focused to detect early signs of intolerance or allergic response. Safe preparation involves using sterile glass vials, syringes, and strict aseptic technique. Residual powder, spills, or droplets call for prompt cleanup to reduce any risk of accidental ingestion or eye contact. Unlike simple laboratory chemicals, Iopamidol’s intended clinical use means the margin for error runs thin, and quality control never takes a back seat.
Raw material suppliers extract active pharmaceutical-grade Iopamidol through several chemical synthesis steps governed by rigorous Good Manufacturing Practice (GMP) rules. Supply chain disruptions can affect availability at hospitals and imaging facilities. Access to high-quality chemical precursors ensures each batch passes potency, purity, and sterility tests. Strong regulatory oversight and transparent sourcing play a crucial role for patient safety. Iopamidol also underscores the importance of reliable infrastructure within healthcare systems. Even a modest production delay or interrupted shipment can postpone urgent diagnostic care, especially in remote or underserved communities.
Understanding Iopamidol’s molecular make-up, physical properties, regulatory requirements, and safe handling practices isn’t just chemistry for its own sake. It means better patient outcomes when people overseeing imaging studies have confidence that the contrast agent does its job, safely and without surprises. Diagnostic imaging stands as a linchpin in modern medicine, but it depends on substances like Iopamidol performing as advertised, batch after batch. Greater awareness, tight manufacturing controls, and reliable distribution ultimately support the level of care that everyone deserves—where accurate results flow from a blend of scientific know-how and trust in the materials brought into every examination room.
